David L. Lakey, M.D., Commissioner of the Texas Department of State Health Services, discusses the handling of the patient with Ebola.
CDC Director Dr. Tom Frieden provides insight to the spread of Ebola, and announces an individual traveling from Liberia to the United States has been diagnosed with Ebola in Texas.
CNBC's Melissa Lee reports pharmaceutical companies with potential Ebola treatments are on the move after hours, as well as airline stocks.
Sarepta President and CEO Chris Garabedian says his company has enough clinical trial quality drug on hand to treat a couple dozen Ebola patients if requested.
CNBC's Meg Tirrell reports Texas health officials have confirmed the Ebola patient is in Texas, and had a recent history of travel to West Africa.
Shares of pharmaceutical companies working on a drug to treat Ebola spiked after the CDC confirmed the first case diagnosed in the U.S.
The CDC has confirmed the first Ebola case diagnosed in the U.S. The "Fast Money" traders discuss the companies spiking on the news.
The CDC has confirmed the first Ebola case diagnosed in the U.S. and will hold a news conference at 5:30PM E.T. Tuesday. CNBC's Meg Tirrell has the details.
Discussing how new government rules could impact health care inversion deals, with CNBC's Meg Tirrell and Les Funtleyder, Esquared Asset Management.
A new breast cancer drug from Roche showed "unprecedented" benefits in a clinical trial, reports CNBC's Meg Tirrell.
A new breast cancer drug from Roche has shown "unprecedented" benefits in extending lives in a clinical trial.
A breast cancer drug from Roche known as Perjeta helped patients live nearly 16 months longer compared with Herceptin and chemotherapy alone. CNBC's Meg Tirrell provides insight to the data.
The World Bank on Thursday announced it would give another $170 million to help West African countries contain the spread of the Ebola virus.
Discussing how the Treasury Department's new rules to end tax inversions could impact the pharma deals, with Michael Faerm, Wells Fargo Securities.
The world's attention may have shifted to U.S. airstrikes on Syria, but West Africa continues to be ravaged by the worst outbreak of Ebola.
CNBC's David Faber reports significant talks are taking place between Allergan and Salix Pharmaceuticals, and how the potential deal impacts Valeant. Jim Cramer explains how Wall Street perceives the potential buy.
Merck agrees to acquire Sigma-Aldrich for $17 billion in cash to boost its life science business.
Karl Ludwig-Kley Merck KGAA, and Rakesh Sachdev, Sigma-Aldrich president & CEO, discuss Merck's acquisition of Sigma-Aldrich and the future of life sciences and technology.
An erectile dysfunction drug that reduces by half the time patients need to take the pill has been approved by the U.S. Food and Drug Administration.
CNBC's Meg Tirrell, and Scott Gottlieb, American Enterprise Institute, discuss the latest developments in controlling the Ebola epidemic.